Biodexa Pharmaceuticals PLC (BDRX) Price Prediction & ForecastBDRXBiodexa Pharmaceuticals PLC

Alphio's BDRX stock price prediction model matches the current Biodexa Pharmaceuticals PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.86 (-0.77%). The 1-week path is $0.87 (+0.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Biodexa Pharmaceuticals (BDRX) is not a good buy right now due to its extremely low RSI of 7.9, indicating it is oversold, and a staggering year-to-date change of -92.94%. The stock has shown significant volatility, with a recent 5-day decline of 31.65%, suggesting a lack of stability and investor confidence. The main risk is its negative forward P/E ratio of 0, indicating no earnings growth expected in the near future, which could lead to further price declines.

Biodexa Pharmaceuticals PLC (BDRX) last closed at $0.8681, losing -3.54%. These facts feed the 1-day and 1-week BDRX price prediction above.